Skip to content

Clinical Effectiveness of the Modified WalkFlex DB Splint in Children With Congenital Talipes Equinovarus (CTEV)

Clinical Effectiveness of the Modified WalkFlex DB Splint in Children With Congenital Talipes Equinovarus (CTEV): A Prospective Pilot Study.

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07055672
Enrollment
15
Registered
2025-07-09
Start date
2025-03-17
Completion date
2026-02-28
Last updated
2025-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Talipes Equinovarus

Brief summary

This pilot study aims to evaluate the effectiveness of the Modified WalkFlex DB Splint in the maintenance phase of Congenital Talipes Equinovarus (CTEV) treatment following successful correction through the Ponseti method. The traditional Denis Browne splint, though widely used, often limits patient mobility and can result in poor compliance. In response to these limitations, the Modified WalkFlex DB Splint was designed to offer increased flexibility at the knee and hip joints, allowing for improved function and easier ambulation while maintaining foot correction.

Detailed description

This is a prospective observational study including 12-15 children aged between 3 months to 3 years who have completed the casting phase.

Interventions

COMBINATION_PRODUCTModified WalkFlex DB Splint (Intervention Arm)

Application of the Modified WalkFlex Denis Browne (DB) Splint Children with corrected idiopathic clubfoot will use the Modified WalkFlex DB Splint for maintenance. This splint allows knee and some hip movement and includes a detachable bar for walking. It will be used after Ponseti casting, and patients will be followed at 1 and 3 months to check splint tolerance, maintenance of correction (using Pirani score), and any signs of relapse

Sponsors

Superior University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
3 Months to 3 Years
Healthy volunteers
No

Inclusion criteria

* children aged 3 months to 3 years diagnosed with idiopathic congenital talipes equinovarus (CTEV) * who have completed the correction phase using the Ponseti method and are starting the bracing phase. * Informed consent from parents or guardians and willingness to attend follow-ups at 1 and 3 months is required

Exclusion criteria

* Children with non-idiopathic clubfoot (e.g., syndromic or neuromuscular) * other congenital limb deformities * or poor compliance with treatment and follow-up will be excluded

Design outcomes

Primary

MeasureTime frameDescription
Pirani Score12 MonthsUsed to assess the severity of clubfoot deformity. It consists of six clinical signs divided into midfoot and hindfoot scores. Each sign is scored as 0 (normal), 0.5 (moderate), or 1 (severe). The total score ranges from 0 (normal foot) to 6 (severe deformity).
Relapse Assessment Checklist (Clinical Observation)12 MonthsObservation-based checklist used at 1-month and 3-month follow-ups to check for signs of relapse such as equinus, varus, adductus, or cavus. Relapse is defined as the recurrence of one or more of these deformities after initial correction.
Parental/Guardian Feedback Questionnaire (Custom/Adapted)12 MonthsA structured feedback form to assess splint tolerance, ease of use, and parental satisfaction. Responses are collected using a 5-point Likert scale (1 = Strongly Disagree, 5 = Strongly Agree) on questions regarding comfort, usability, and perceived effectiveness of the splint.

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026